INMODE LTD IS -01
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more
INMODE LTD IS -01 (154) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INMODE LTD IS -01 (154) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INMODE LTD IS -01 - Net Assets Trend (None–None)
This chart illustrates how INMODE LTD IS -01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INMODE LTD IS -01 (None–None)
The table below shows the annual net assets of INMODE LTD IS -01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INMODE LTD IS -01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INMODE LTD IS -01 Competitors by Market Cap
The table below lists competitors of INMODE LTD IS -01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NFI Group Inc
PINK:NFYEF
|
$681.44 Million |
|
freee K.K
PINK:FREKF
|
$681.68 Million |
|
Olav Thon Eien
OL:OLT
|
$681.70 Million |
|
Everlight Electronics Co Ltd
TW:2393
|
$681.87 Million |
|
Deutsche Pfandbriefbank AG
OTCGREY:PBBGF
|
$681.08 Million |
|
Beijing Zhidemai Technology
SHE:300785
|
$680.81 Million |
|
Hnac Technology Co Ltd
SHE:300490
|
$680.58 Million |
|
Shandong Mining Machinery Group Co Ltd
SHE:002526
|
$680.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INMODE LTD IS -01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INMODE LTD IS -01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INMODE LTD IS -01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INMODE LTD IS -01's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INMODE LTD IS -01 (154) | €- | N/A | N/A | $681.19 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $18.56 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.44 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.18 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.94 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $615.93 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |